News

gut.bmj4d
The FODMAP diet: more than just a symptomatic therapy?
Correspondence to Professor Peter R Gibson, Department of Gastroenterology, Monash University and Alfred Health, Melbourne, VIC 3004, Australia; Peter.gibson{at}monash.edu Reasons behind such ...
Gut8d
A rare cause of long-segment colitis
A 65-year-old previously well man presented with 3 weeks of generalised abdominal pain and diarrhoea up to three times per ...
gut.bmj14d
Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants
Objective Iron-containing micronutrient powders (MNPs) reduce anaemia in African infants, but the current high iron dose (12.5 mg/day) may decrease gut Bifidobacteriaceae and Lactobacillaceae, and ...
gut.bmj16d
High-protein diets alleviate tumour growth and drug resistance by promoting AKT aggregation and turnover
Background Despite the long-standing recommendations of high-protein diets for patients with cancer, the precise mechanisms of this dietary approach in benefiting tumour suppression and enhancing ...
gut.bmj16d
Purastat post-EMR: unresolved questions from the PURPLE trial
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj19d
Withdrawal of antitumour necrosis factor in patients with inflammatory bowel disease in remission: a randomised placebo-controlled clinical trial of GETECCU
We read with interest Gisbert et al ’s report of EXIT, a randomised controlled trial (RCT) withdrawing anti-TNF in patients with inflammatory bowel disease (IBD), while continuing immunomodulators.1 ...
gut.bmj19d
Prevention of rebleeding after primary haemostasis using haemostatic powder in non-variceal upper gastrointestinal bleeding: a multicentre randomised controlled trial
2 Utah-Inha DDS & Advanced Therapeutics Research Center, Incheon, Korea (the Republic of) Background Non-variceal upper gastrointestinal bleeding (NVUGIB) remains a major cause of morbidity and ...
gut.bmj22d
Multicentre RCT of a self-assembling haemostatic gel to prevent delayed bleeding following EMR—an underpowered sample size calculation
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj1mon
BSG/ACPGBI guidance on the management of colorectal polyps in patients with limited life expectancy
Background Determining optimal management of colorectal polyps in patients with limited life expectancy of under 10 years can be difficult, due to challenges balancing an uncertain natural history of ...
gut.bmj1mon
Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction
Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...
gut.bmj1mon
DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis
Background Inflammatory bowel diseases (IBDs) are characterised by dysbiosis and a leaky gut. The NADPH oxidase dual oxidase 2 (DUOX2) is upregulated in patients with IBD, yet its role in driving the ...
gut.bmj1mon
Menopausal hormone therapy is a risk factor for microscopic colitis: findings from a nationwide, matched case–control study
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...